2025-04-16 - Analysis Report
## Albemarle Corp (ALB) Stock Report

**0. Overview:**

Albemarle Corp (ALB) is a leading global producer of lithium and other specialty chemicals.


**1. Performance Comparison & Alpha/Beta Analysis:**

ALB's cumulative return (0.61) significantly underperformed the S&P 500 (VOO) cumulative return (66.27). The provided data shows a large negative divergence (-65.7).  The provided alpha and beta values show significant volatility and varying performance relative to the market.  High positive alphas suggest outperformance while negative alphas indicate underperformance.  The beta values fluctuate considerably, suggesting variable sensitivity to market movements. Noteworthy is the extremely negative CAGR from 2023-2025, suggesting a substantial downturn.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 99.0% | 7.7% | 70.0% | 0.0 | 13.7 |
| 2016-2018  | 13.0% | 58.1% | -5.0% | 0.0 | 8.4 |
| 2017-2019  | -45.0% | 58.1% | -74.0% | -0.0 | 8.1 |
| 2018-2020  | 101.0% | 62.9% | 75.0% | 0.7 | 16.6 |
| 2019-2021  | 268.0% | 62.9% | 214.0% | 0.8 | 26.5 |
| 2020-2022  | 239.0% | 75.8% | 233.0% | 1.1 | 24.8 |
| 2021-2023  | -53.0% | 77.6% | -69.0% | 0.6 | 16.6 |
| 2022-2024  | -204.0% | 77.6% | -221.0% | 0.8 | 10.1 |
| 2023-2025  | -347.0% | 77.6% | -361.0% | 2.2 | 6.3 |


**2. Recent Price Movement:**

* Closing Price: $54.01
* 5-day moving average: $56.65
* 20-day moving average: $67.26
* 60-day moving average: $75.48

The stock price is significantly below all three moving averages, indicating a downtrend.  The recent price change (-$5.89) shows a substantial drop from the previous close.


**3. Technical Indicators & Expected Return:**

* MRI: 0.4175 (Medium Risk)
* RSI: 27.07 (Oversold territory, suggesting potential bounce but not confirming an uptrend)
* PPO: -2.02 (Negative, indicating bearish momentum)
* 20-day Relative Divergence Change: -2.9 (Short-term downtrend)
* Expected Return: 14372.6% (This exceptionally high number needs further investigation and clarification.  It's likely an error or miscalculation.  A realistic long-term expectation needs proper modeling and context.)

The significant negative price change (-$5.89) points to a sharp price drop.


**4. Recent Earnings Analysis:**

| Date       | EPS     | Revenue     |
|------------|---------|-------------|
| 2024-11-06 | -9.45   | $1.35 B     |
| 2024-07-31 | -1.96   | $1.43 B     |
| 2024-05-01 | -0.08   | $1.36 B     |
| 2023-11-01 | 2.58    | $2.31 B     |
| 2024-11-06 | 2.58    | $2.31 B     | *(Note: Duplicate entry.  Potential data error)*


There's a clear decline in EPS and potentially revenue in the last three quarters. The significant negative EPS in the last two quarters is alarming and requires further investigation.  The duplicate entry for November 6th, 2024 needs correction.



**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $1.23B | 11.22% |
| 2024-09-30 | $1.35B | -7.68% |
| 2024-06-30 | $1.43B | -0.74% |
| 2024-03-31 | $1.36B | 2.86% |
| 2023-12-31 | $2.36B | -29.88% |

**Capital and Profitability:**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2024-12-31 | $9.96B | 0.76% |
| 2024-09-30 | $10.24B | -10.44% |
| 2024-06-30 | $11.22B | -1.68% |
| 2024-03-31 | $11.53B | 0.02% |
| 2023-12-31 | $9.41B | -6.56% |

Revenue has decreased significantly in recent quarters, accompanied by fluctuating and mostly negative profit margins.  ROE also shows considerable volatility and negative values in recent periods.


**6. Overall Analysis:**

ALB is currently experiencing a significant downturn.  The stock is significantly underperforming the S&P 500, showing negative momentum across several indicators (RSI, PPO, price action).  Recent earnings reveal substantial losses and declining revenue.  The financial statements reflect a concerning trend of declining profitability and fluctuating equity.  The exceptionally high expected return requires further scrutiny.  Before considering any investment, further due diligence is crucial, including analysis of the causes for the recent negative performance and a more realistic assessment of future prospects. The data inconsistencies (duplicate entry in earnings data) further highlight the need for more reliable and complete data before drawing solid conclusions.
